Skip to content

Clinical trials

Seizures trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Country / region: Czechia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20081
20092
20101
20112
20121
20131
20151
20161
20183
20193
20211
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Active, not recruiting2
Enrolling by invitation2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.6
Eisai Inc.3
Xenon Pharmaceuticals Inc.3
Biohaven Therapeutics Ltd.2
Jazz Pharmaceuticals2
Neurocrine Biosciences2
Sumitomo Pharma America, Inc.2
UCB Biopharma SRL2
Astellas Pharma Global Development, Inc.1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures27
Epilepsy21
Epilepsies, Partial8
Drug Resistant Epilepsy5
Blood Loss, Surgical1
Epilepsy, Complex Partial1
Hemorrhage1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.